Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
159
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

More than ten percent of relapses occur after five years in AML patients with NPM1 mutation

Sarah BertoliService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; ;Université Toulouse III Paul Sabatier, Toulouse, France; ;Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France; Correspondence[email protected]
,
Suzanne TavitianService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
,
Emilie BérardService d’Epidémiologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; ;UMR 1027, INSERM-Université de Toulouse III, Toulouse, France;
,
Véronique Mansat-De MasUniversité Toulouse III Paul Sabatier, Toulouse, France; ;Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France; ;Laboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
,
Laetitia LargeaudUniversité Toulouse III Paul Sabatier, Toulouse, France; ;Laboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
,
Noémie GadaudService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
,
Jean-Baptiste RieuLaboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
,
François VergezUniversité Toulouse III Paul Sabatier, Toulouse, France; ;Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France; ;Laboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
,
Isabelle LuquetLaboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
,
Françoise HuguetService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
,
Audrey SarryService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
,
Eric DelabesseUniversité Toulouse III Paul Sabatier, Toulouse, France; ;Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France; ;Laboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
&
Christian RécherService d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; ;Université Toulouse III Paul Sabatier, Toulouse, France; ;Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France;
show all
Pages 1226-1229 | Received 27 Aug 2019, Accepted 14 Dec 2019, Published online: 05 Feb 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

CR has received research grants from Amgen, Novartis, Celgene, Jazz Pharmaceuticals, Agios, Chugai, Sunesis, Astellas and MaatPharma and is an advisor for Abbvie, Sunesis, Janssen, Jazz, Novartis, Celgene, Astellas, Daiichi-Sankyo, Macrogenics and Pfizer. FH is an advisor for Amgen, BMS, Celgene, Incyte, Jazz Pharma, Novartis, and Pfizer. ST and ED are advisors for Novartis. SB is an advisor for Daiichi-Sankyo, Sanofi, Jazz Pharmaceuticals and Astellas.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.